Our Portfolio Company is creating a paradigm shift in haemodialysis. Its cartridge-based dialysis systems are compact and simple enough to use at home, but also deliver the same clinical quality treatment with high flow rates.
Quanta Dialysis Technologies is a technology-enabled solutions provider based that aims to improve the lives of dialysis patients through beautifully engineered innovation. Its lead product, SC+, is designed to empower dialysis patients by giving them greater freedom, convenience and control over the delivery of their life-sustaining therapy. SC+ is CE marked for sale in the UK and Europe. As of January 2021 Quanta Dialysis Technologies is bringing its small, lightweight blood purification system to the U.S., following its commercial launch in the U.K. last year and clinical pilots with the country’s National Health Service. With a new FDA clearance in hand, the British company plans to roll out its portable SC+ hemodialysis machine to a variety of care settings on the other side of the pond.
As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.